Be part of the knowledge.™

AEDs: Limiting Rates of Sudden Cardiac Death

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Dr. Gust Bardy, president of the Seattle Institute for Cardiac Research and lead investigator of the Home Automated External Defibrillator Trial (HAT), published in the New England Journal of Medicine, will discuss the use of automated external defibrillators, both at home and in public locations, as a strategy to reduce mortality rates among patients who are at higher risk for sudden cardiac death.

Gust Bardy, MD

Matthew J. Sorrentino, MD, FACC, FASH

Matthew J. Sorrentino, MD, FACC, FASH

Recommended

Details

Presenters

Overview
Dr. Gust Bardy, president of the Seattle Institute for Cardiac Research and lead investigator of the Home Automated External Defibrillator Trial (HAT), published in the New England Journal of Medicine, will discuss the use of automated external defibrillators, both at home and in public locations, as a strategy to reduce mortality rates among patients who are at higher risk for sudden cardiac death.

Gust Bardy, MD

Matthew J. Sorrentino, MD, FACC, FASH

Matthew J. Sorrentino, MD, FACC, FASH

Program Chapters

Segment Chapters

Playlist:

Recommended

Phase 3 study results of plozasiran in patients with FCS

CME/CE Broadcast Replay

Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference

Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time

HF Management for Patients with Comorbid Conditions

Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF

FINE-HEART Pooled Analysis

Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial

NYHA FC and Finerenone Response: Clinical Trial Insights